Current guidelines recommend transdermal delivery of testosterone for post-menopausal women seeking treatment for hypoactive sexual desire disorder. Medherant’s TEPI patch has been developed to fill ...

As consumer attention around transdermal wellness patches grows in 2026, interest has also expanded around ingredient visibility, product variety, and policy transparency across the category. This ...